Picture of Rohto Pharmaceutical logo

4527 — Rohto Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Rohto -6-MTH group results

Nov 11 (Reuters)-  
             Rohto Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   6 months ended      6 months ended       Year to  
                  Sep 30, 2016        Sep 30, 2015     Mar 31, 2017  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales               71.30               77.34           150.50     
                   (-7.8 pct)          (+15.0 pct)      (-9.9 pct)   
  Operating            6.47                7.17            13.10     
                   (-9.9 pct)          (+38.0 pct)      (-16.5 pct)  
  Recurring            6.82                7.51            13.40     
                   (-9.1 pct)          (+33.4 pct)      (-12.6 pct)  
  Net                  4.19                4.87             7.50     
                   (-14.0 pct)         (+36.2 pct)      (-17.6 pct)  
  EPS               36.83 yen           42.88 yen        65.88 yen   
  EPS Diluted       36.68 yen           42.70 yen                    
  Ann Div                               20.00 yen        21.00 yen   
  -Q2 div           10.00 yen           10.00 yen                    
  -Q4 div                               10.00 yen        11.00 yen   
   
  NOTE - Rohto Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Rohto Pharmaceutical

See all news